Clinical Trial Update: Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection [Phase 3]

View source ↗

Summary

Phase III trial comparing perioperative SOX versus XELOX or SOX alone as post-operative chemotherapy in locally advanced gastric adenocarcinoma with D2 dissecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Carcinoma

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)
• SOX (Oxaliplatin + S-1) (oxaliplatin)
• XELOX (Oxaliplatin + Capecitabine) (oxaliplatin)

Snippet

Sponsor: Peking University | Conditions: Advanced Gastric Carcinoma | Phase 3 | Status: UNKNOWN